Recordati reported EUR493.93M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Almirall EUR 517.43M 265.53M Jun/2025
GlaxoSmithKline GBP 5.96B 663M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Orion EUR 311.9M 35.2M Jun/2025
Sanofi EUR 9.02B 702M Jun/2025